🟢 Novanta is trading 5.9% up today after Q2 earnings beat and raised guidance

Novanta is trading 5.9% up now at $166.54 after its August 5 earnings release beat expectations.

• Q2 revenue was $265.8 million, with adjusted EPS of $0.89.
• Management raised full-year revenue guidance to $1.13 billion-$1.14 billion and adjusted EPS guidance to $3.68-$3.74.
• Q3 revenue guidance was also strong, supporting continued investor optimism around organic growth and the Riverpoint Medical acquisition.